Strongbridge Biopharma plc·4

May 18, 7:14 PM ET

Steen Marten 4

4 · Strongbridge Biopharma plc · Filed May 18, 2021

Insider Transaction Report

Form 4
Period: 2021-05-18
Steen Marten
Director
Transactions
  • Award

    Ordinary Shares

    2021-05-18+40,00081,914 total(indirect: By HealthCap VI, L.P.)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest in full on May 18, 2022, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Based on his affiliation with HealthCap VI, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -